Satsuma Pharmaceuticals Inc – Company Profile Satsuma Pharmaceuticals Inc – Company Profile

Satsuma Pharmaceuticals Inc (Satsuma), a subsidiary of Shin Nippon Biomedical Laboratories Ltd, is a biopharmaceutical company that develops novel therapeutic products for the acute treatment of migraine. The Company is focused on developing a therapeutic product for the acute treatment of migraine. The Company's product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate (DHE), which is designed to be self-administered with a pre-filled, single-use, nasal delivery device. Satsuma is headquartered in South San Francisco, California,...